Get your Drug Design, Development and Therapy paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4.8
Authored by Sumalatha Gangadhar | Published on 10 August, 2026
Submitting to Drug Design, Development and Therapy goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the Drug Design, Development and Therapy guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
It is a manuscript shell aligned to Drug Design, Development and Therapy. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the Drug Design, Development and Therapy journal page before you draft.
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the Drug Design, Development and Therapy guide for authors lists, and cite figures and tables in order.
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the Drug Design, Development and Therapy guide for authors before you submit.
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through the journal's submission system.
| Element | Drug Design Development Ther requirement |
|---|---|
| Abstract | Original research papers require a structured abstract. Both structured and unstructured abstracts should be no more than 300 words |
| Main text | Word counts are not specified. General guidance: shorter items range from 1000 to 3000 words and reviews from 3000 to 7,500 words |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| Keywords | 3-6 keywords required |
| References | AMA (American Medical Association) style, based on Vancouver/ICMJE style. References are numbered sequentially in text using superscript Arabic numerals and listed numerically in order of citation |
| Peer review | Single-anonymous (single-blind) peer review |
| Submission | www.dovepress.com/submit_to_journal.php?tf_code=DDDT |
Read the Drug Design, Development and Therapy guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to Drug Design, Development and Therapy in under a page.
Skim two or three recent Drug Design Development Ther papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the Drug Design, Development and Therapy journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Do one focused pass against the Drug Design, Development and Therapy guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through the journal's submission system.